by Ann McNary, JD Ms. McNary is Senior Risk Manager, Professional Risk Management Services, Arlington, Virginia. Innov Clin Neurosci. 2015;12(3–4):37–40.
Innov Clin Neurosci. 2015;12(3–4):11–13.
Innov Clin Neurosci. 2015;12(3–4):10–11.
Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting
by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E.
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD; Stephen K. Brannan, MD; Andrew K. Krystal, MD, MSc; Joop M A van Gerven, MD, PhD; Atul Mahableshwarkar, MD; and